Showing results (151-160 of 2,811) with videos related to
Sort By:
Pageof 282
Diabetes Technology & Therapeutics|May 28, 2025
Initiation of Continuous Glucose Monitoring and Mortality in Type 2 DiabetesPeter D Reaven, Sharon Macwan, Michelle Newell, et al.Diabetes Technology & Therapeutics|May 12, 2025
An Exploratory Cost-Effectiveness Analysis of Immune Therapy in Delaying the Initiation of Automated Insulin Delivery Systems in Type 1 DiabetesShweta Mital, Michael J Haller, Desmond A Schatz, et al.Diabetes Technology & Therapeutics|February 17, 2026
Intermittently Scanned Continuous Glucose Monitoring Enhances Weight Loss and Adherence in Women with Obesity: A Randomized Controlled TrialMarina Gradiser, Ines Bilic-Curcic, Ines Okun, et al.Diabetes Technology & Therapeutics|February 6, 2026
Safety and Feasibility of Algorithmic Continuous Glucose Monitoring-Based Titration in People with Type 2 Diabetes Using Insulin Degludec, With or Without Noninsulin Glucose-Lowering Drugs: A 16-Week Randomized Controlled TrialAnas El Fathi, Ralf Nass, Carol J Levy, et al.Diabetes Technology & Therapeutics|February 1, 2026
Potential Role of Inhaled Insulin in the Management of Gestational Diabetes Mellitus and Pediatric Type 1 DiabetesLori M Laffel, Amy M ValentDiabetes Technology & Therapeutics|February 1, 2026
Pulmonary Safety and Clinical Considerations for Inhaled Insulin: A Comprehensive ReviewJanet B McGill, Oscar M MayerDiabetes Technology & Therapeutics|February 1, 2026
Use of Inhaled Insulin with Automated Insulin Delivery SystemsEda Cengiz, Roy W BeckDiabetes Technology & Therapeutics|February 1, 2026
The Potential of Inhaled Insulin Therapy in Overcoming Treatment Barriers in People with Insulin-Treated DiabetesKorey K Hood, William H PolonskyDiabetes Technology & Therapeutics|January 22, 2026
A Real-World Data Assessment of Pulmonary Toxicity of Inhaled Insulin for DiabetesTodd L Burstain, Irl B Hirsch, Roy W BeckDiabetes Technology & Therapeutics|March 20, 2025
Personalized Hemoglobin A1c Shows Better Correlation with Mean Glucose than Laboratory Hemoglobin A1c in Ugandan Youth with Type 1 Diabetes, but Mean Glucose Is Not Clinically Useful in This Population Due to Extreme Glucose VariabilityThereza Piloya-Were, Catherine Nyangabayaki, Timothy C Dunn, et al.Pageof 282